Luteolin Alleviates the TNF-α-Induced Inflammatory Response of Human Microvascular Endothelial Cells via the Akt/MAPK/NF-κB Pathway
2024

Luteolin Reduces Inflammation in Endothelial Cells

publication Evidence: moderate

Author Information

Author(s): Qing-Yu Lu, Li Guo, Qi-Yun Zhang, Fu-Mei Yang, Shu-Ting Zhou, Qian-Yun Sun

Primary Institution: Guizhou Medical University

Hypothesis

This study aims to investigate the effects and mechanisms of luteolin on TNF-α-induced inflammatory injury in human microvascular endothelial cells.

Conclusion

Luteolin effectively suppresses TNF-α-induced inflammatory injury in endothelial cells via the Akt/MAPK/NF-κB pathway.

Supporting Evidence

  • Luteolin treatment significantly reduced the expression of proinflammatory cytokines ICAM-1, IL-6, IL-8, and MCP-1.
  • Luteolin inhibited the phosphorylation of NF-κB p65, MAPK, and Akt signaling pathways.
  • Treatment with luteolin resulted in decreased transcriptional activity of NF-κB and AP-1.

Takeaway

Luteolin is a natural compound that helps reduce inflammation in blood vessel cells, which can be important for heart health.

Methodology

The study used human microvascular endothelial cells treated with TNF-α and varying concentrations of luteolin to assess inflammatory responses through various assays including ELISA and western blot.

Limitations

The study primarily focused on microvascular endothelial cells, and the findings may not be generalizable to other cell types.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/mi/6393872

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication